BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21768498)

  • 1. Acute generalized exanthematous pustulosis induced by methylphenidate: a new adverse effect.
    Heinzerling LM; Pichler W; Anliker MD
    Arch Dermatol; 2011 Jul; 147(7):872-3. PubMed ID: 21768498
    [No Abstract]   [Full Text] [Related]  

  • 2. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Killeen MR
    J Child Fam Nurs; 2000; 3(1):46-8. PubMed ID: 11022478
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter to the editor: Comment on 'Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder'.
    Olders H
    J Pediatr Psychol; 2009; 34(1):108-9; author reply 110-2. PubMed ID: 19136567
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylphenidate-induced erections in a prepubertal child.
    Kelly BD; Lundon DJ; McGuinness D; Brady CM
    J Pediatr Urol; 2013 Feb; 9(1):e1-2. PubMed ID: 22552161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulants for ADHD in child patients with Tourette's syndrome: the issue of relative risk.
    Gadow KD; Sverd J
    J Dev Behav Pediatr; 1990 Oct; 11(5):269-71; discussion 272. PubMed ID: 1979565
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
    Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
    Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
    [No Abstract]   [Full Text] [Related]  

  • 7. Terbinafine-induced acute generalized exanthematous pustulosis (AGEP) responsive to high dose intravenous corticosteroid.
    Ibrahimi OA; Gunawardane N; Sepehr A; Reynolds RV
    Dermatol Online J; 2009 Sep; 15(9):8. PubMed ID: 19930995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate transdermal system.
    Mays DA; Findling R
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223. PubMed ID: 16292112
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
    Hollis CP; Thompson A
    Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excessive masturbation and hypersexual behavior associated with methylphenidate.
    Bilgiç A; Gürkan K; Türkoğlu S
    J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):789-90. PubMed ID: 17581441
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular effects of methylphenidate.
    Daniels SR
    J Pediatr; 2009 Jul; 155(1):A3. PubMed ID: 19559283
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.
    Ghanizadeh A
    J Pediatr Urol; 2008 Aug; 4(4):306-7. PubMed ID: 18644535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal methylphenidate (Daytrana) for ADHD.
    Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological management of treatment-induced insomnia in ADHD.
    Kratochvil CJ; Lake M; Pliszka SR; Walkup JT
    J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):499-501. PubMed ID: 15843773
    [No Abstract]   [Full Text] [Related]  

  • 15. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract]   [Full Text] [Related]  

  • 16. Methylphenidate and chromosome damage.
    Jacobson-Kram D; Mattison D; Shelby M; Slikker W; Tice R; Witt K
    Cancer Lett; 2008 Feb; 260(1-2):216-8. PubMed ID: 18055105
    [No Abstract]   [Full Text] [Related]  

  • 17. [Amicrobial pustulosis of the skin folds and autoimmune erythroblastopenia].
    Saint-Jean M; Gagey-Caron V; Jossic F; Barbarot S; Hamidou M; Stalder JF
    Ann Dermatol Venereol; 2011 May; 138(5):399-404. PubMed ID: 21570565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of methylphenidate on the quality of life in children with epilepsy and attention deficit hyperactivity disorder: and open-label study using an osmotic-controlled release oral delivery system.
    Yoo HK; Park S; Wang HR; Lee JS; Kim K; Paik KW; Yum MS; Ko TS
    Epileptic Disord; 2009 Dec; 11(4):301-8. PubMed ID: 20007067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate-induced obsessive-compulsiveness.
    Kouris S
    J Am Acad Child Adolesc Psychiatry; 1998 Feb; 37(2):135. PubMed ID: 9473905
    [No Abstract]   [Full Text] [Related]  

  • 20. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
    Kraemer M; Uekermann J; Wiltfang J; Kis B
    Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.